価格表

在庫・価格 : 2024年05月06日 17時58分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-IgM, Mouse, Goat-Poly, HRP
データシート
A90-101P BETベチル ラボラトリーズ
Bethyl Laboratories, Inc.
1 mg ¥33,000
(未発注)
追加

在庫・価格 : 2024年05月06日 17時58分 現在

Anti-IgM, Mouse, Goat-Poly, HRP

  • 商品コード:A90-101P
  • メーカー:BET
  • 包装:1mg
  • 価格: ¥33,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Siddiqui AA et al. Enhancement of Sm-p80 (large subunit of calpain) induced protective immunity against Schistosoma mansoni through co-delivery of interleukin-2 and interleukin-12 in a DNA vaccine formulation. Vaccine 2003 Jun;21(21-22):2882-9
Siddiqui AA et al
2003/01/01
PubMed
2 Yurino H et al. Endocrine disruptors (environmental estrogens) enhance autoantibody production by B1 cells. Toxicol. Sci. 2004 Sep;81(1):139-47
Yurino H et al
2004/01/01
PubMed
3 Brummel R et al. Activation of marginal zone B cells from lupus mice with type A(D) CpG-oligodeoxynucleotides. J. Immunol. 2005 Feb;174(4):2429-34
Brummel R et al
2005/01/01
PubMed
4 Thumbikat P et al. Antigen-specific responses accelerate bacterial clearance in the bladder. J. Immunol. 2006 Mar;176(5):3080-6
Thumbikat P et al
2006/01/01
PubMed
5 Koide H et al. Size-dependent induction of accelerated blood clearance phenomenon by repeated injections of polymeric micelles. Int J Pharm 2012 Aug;432(1-2):75-9
Koide H et al
2012/01/01
PubMed
6 Wong WF et al. Runx1 deficiency in CD4+ T cells causes fatal autoimmune inflammatory lung disease due to spontaneous hyperactivation of cells. J. Immunol. 2012 Jun;188(11):5408-20
Wong WF et al
2012/01/01
PubMed
7 Abu Lila AS et al. Multiple administration of PEG-coated liposomal oxaliplatin enhances its therapeutic efficacy: a possible mechanism and the potential for clinical application. Int J Pharm 2012 Nov;438(1-2):176-83
Abu Lila AS et al
2012/01/01
PubMed
8 Allison DF et al. Modification of RelA by O-linked N-acetylglucosamine links glucose metabolism to NF-κB acetylation and transcription. Proc. Natl. Acad. Sci. U.S.A. 2012 Oct;109(42):16888-93
Allison DF et al
2012/01/01
PubMed
9 Almer G et al. Interleukin-10: an anti-inflammatory marker to target atherosclerotic lesions via PEGylated liposomes. Mol. Pharm. 2013 Jan;10(1):175-86
Almer G et al
2013/01/01
Applications: ELISA PubMed
10 Lin SC et al. Different immunity elicited by recombinant H5N1 hemagglutinin proteins containing pauci-mannose, high-mannose, or complex type N-glycans. PLoS ONE 2013;8(6):e66719
Lin SC et al
2013/01/01
PubMed
11 Miura T et al. Histo-blood group antigen-like substances of human enteric bacteria as specific adsorbents for human noroviruses. J. Virol. 2013 Sep;87(17):9441-51
Miura T et al
2013/01/01
PubMed
12 Hess C et al. T cell-independent B cell activation induces immunosuppressive sialylated IgG antibodies. J. Clin. Invest. 2013 Sep;123(9):3788-96
Hess C et al
2013/01/01
PubMed
13 Magri G et al. Innate lymphoid cells integrate stromal and immunological signals to enhance antibody production by splenic marginal zone B cells. Nat. Immunol. 2014 Apr;15(4):354-64
Magri G et al
2014/01/01
PubMed
14 Selenica ML et al. Epitope analysis following active immunization with tau proteins reveals immunogens implicated in tau pathogenesis. J Neuroinflammation 2014;11:152
Selenica ML et al
2014/01/01
PubMed
15 Suzuki T et al. Influence of dose and animal species on accelerated blood clearance of PEGylated liposomal doxorubicin. Int J Pharm 2014 Oct;476(1-2):205-212
Suzuki T et al
2014/01/01
PubMed
16 Yabe T et al. Development of a photoreactive probe-based system for detecting heparin. Anal. Biochem. 2015 Mar;472:1-6
Yabe T et al
2015/01/01
PubMed
  • No.: 1
  • 文献情報:
    Siddiqui AA et al. Enhancement of Sm-p80 (large subunit of calpain) induced protective immunity against Schistosoma mansoni through co-delivery of interleukin-2 and interleukin-12 in a DNA vaccine formulation. Vaccine 2003 Jun;21(21-22):2882-9
    Siddiqui AA et al
    2003/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Yurino H et al. Endocrine disruptors (environmental estrogens) enhance autoantibody production by B1 cells. Toxicol. Sci. 2004 Sep;81(1):139-47
    Yurino H et al
    2004/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Brummel R et al. Activation of marginal zone B cells from lupus mice with type A(D) CpG-oligodeoxynucleotides. J. Immunol. 2005 Feb;174(4):2429-34
    Brummel R et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Thumbikat P et al. Antigen-specific responses accelerate bacterial clearance in the bladder. J. Immunol. 2006 Mar;176(5):3080-6
    Thumbikat P et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Koide H et al. Size-dependent induction of accelerated blood clearance phenomenon by repeated injections of polymeric micelles. Int J Pharm 2012 Aug;432(1-2):75-9
    Koide H et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Wong WF et al. Runx1 deficiency in CD4+ T cells causes fatal autoimmune inflammatory lung disease due to spontaneous hyperactivation of cells. J. Immunol. 2012 Jun;188(11):5408-20
    Wong WF et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Abu Lila AS et al. Multiple administration of PEG-coated liposomal oxaliplatin enhances its therapeutic efficacy: a possible mechanism and the potential for clinical application. Int J Pharm 2012 Nov;438(1-2):176-83
    Abu Lila AS et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Allison DF et al. Modification of RelA by O-linked N-acetylglucosamine links glucose metabolism to NF-κB acetylation and transcription. Proc. Natl. Acad. Sci. U.S.A. 2012 Oct;109(42):16888-93
    Allison DF et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Almer G et al. Interleukin-10: an anti-inflammatory marker to target atherosclerotic lesions via PEGylated liposomes. Mol. Pharm. 2013 Jan;10(1):175-86
    Almer G et al
    2013/01/01
  • 備考:
    Applications: ELISA
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Lin SC et al. Different immunity elicited by recombinant H5N1 hemagglutinin proteins containing pauci-mannose, high-mannose, or complex type N-glycans. PLoS ONE 2013;8(6):e66719
    Lin SC et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Miura T et al. Histo-blood group antigen-like substances of human enteric bacteria as specific adsorbents for human noroviruses. J. Virol. 2013 Sep;87(17):9441-51
    Miura T et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Hess C et al. T cell-independent B cell activation induces immunosuppressive sialylated IgG antibodies. J. Clin. Invest. 2013 Sep;123(9):3788-96
    Hess C et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Magri G et al. Innate lymphoid cells integrate stromal and immunological signals to enhance antibody production by splenic marginal zone B cells. Nat. Immunol. 2014 Apr;15(4):354-64
    Magri G et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Selenica ML et al. Epitope analysis following active immunization with tau proteins reveals immunogens implicated in tau pathogenesis. J Neuroinflammation 2014;11:152
    Selenica ML et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Suzuki T et al. Influence of dose and animal species on accelerated blood clearance of PEGylated liposomal doxorubicin. Int J Pharm 2014 Oct;476(1-2):205-212
    Suzuki T et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Yabe T et al. Development of a photoreactive probe-based system for detecting heparin. Anal. Biochem. 2015 Mar;472:1-6
    Yabe T et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed